Download Our App
'This was odd': GOP senator blows up White House's overnight story on ditched nominee
U.S. Senator Bill Cassidy (R-LA) listens to an aide during a Senate Finance Committee hearing on health care costs on Capitol Hill in Washington, D.C., U.S., November 19, 2025. REUTERS/Jonathan Ernst

'This was odd': GOP senator blows up White House's overnight story on ditched nominee

A Republican senator is publicly disputing the White House’s reason for abruptly dropping President Donald Trump’s pick to lead the Food and Drug Administration on Tuesday night.

The White House pulled the nomination of Dr. Heidi Overton the night before the Senate Health, Education, Labor and Pensions (HELP) Committee was set to vote on it on Wednesday morning. A senior administration official told Axios that Overton “lacks the support on the Hill to move forward with her confirmation.”

Sen. Bill Cassidy (R-La.), the physician who chairs the committee, isn’t buying it.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton,” Cassidy wrote on social media. “The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate.”

Cassidy then offered his own account of what happened. He wrote that “pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues,” and that “the Administration withdrew Dr. Overton rather than make such commitments.”

His post also suggested the White House has wasted its chance to confirm a permanent FDA chief. “Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” he wrote. Democrats take control of the Senate in January.

The post marks a turnaround for Cassidy. When Trump first announced Overton, Cassidy called her stance on vaccines “almost disqualifying,” and at her September hearing he questioned whether she would push back against the president. On Tuesday night, he wrote that his conversations with her “convinced me she would follow the science and push back against decisions that put Americans’ health at risk.”

Overton, a preventive medicine physician and former deputy director of the White House Domestic Policy Council, faced resistance from several sides of the GOP. According to the Wall Street Journal, Republicans were skeptical of her work loosening vaping rules, her push to scale back childhood vaccine recommendations and her past criticism of the abortion pill. The AP reported that she needed support from all 12 Republicans on the committee to advance.

Anti-abortion groups had pressed senators to get firm commitments before voting. Susan B. Anthony Pro-Life America urged them to demand that the FDA restore an in-person dispensing requirement for mifepristone. “Confirmation is not a coronation,” the group’s senior vice president, Erik Baptist, said. At her hearing, Overton declined to prejudge the agency’s ongoing review of the drug.

Report typos and corrections to corrections@rawstory.com.

For customer support contact support@rawstory.com.

Top Stories Recommended For You

YOUR OPINION MATTERS

Should Howard Lutnick be investigated for his ties to the Nvidia scandal?

VOTE NOW
Should Howard Lutnick be investigated for his ties to the Nvidia scandal?